ATE220669T1 - Verbindungen aus der gruppe der 3-aryl-2,4-dioxo- oxazolidine und ihre verwendung in der kosmetik und pharmazie - Google Patents

Verbindungen aus der gruppe der 3-aryl-2,4-dioxo- oxazolidine und ihre verwendung in der kosmetik und pharmazie

Info

Publication number
ATE220669T1
ATE220669T1 AT97933721T AT97933721T ATE220669T1 AT E220669 T1 ATE220669 T1 AT E220669T1 AT 97933721 T AT97933721 T AT 97933721T AT 97933721 T AT97933721 T AT 97933721T AT E220669 T1 ATE220669 T1 AT E220669T1
Authority
AT
Austria
Prior art keywords
dioxo
pharmacy
cosmetics
aryl
compounds
Prior art date
Application number
AT97933721T
Other languages
English (en)
Inventor
Jean-Baptiste Galey
Lionel Breton
Odile Destree
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE220669T1 publication Critical patent/ATE220669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT97933721T 1996-08-01 1997-07-11 Verbindungen aus der gruppe der 3-aryl-2,4-dioxo- oxazolidine und ihre verwendung in der kosmetik und pharmazie ATE220669T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9609748A FR2751965B1 (fr) 1996-08-01 1996-08-01 Nouveaux composes de la famille des aryl-2,4-dioxo-oxazolidines
PCT/FR1997/001289 WO1998005654A1 (fr) 1996-08-01 1997-07-11 Composes de la famille des 3-aryl 2,4 dioxo oxazolidines et leur utilisation en cosmetique et en pharmacie

Publications (1)

Publication Number Publication Date
ATE220669T1 true ATE220669T1 (de) 2002-08-15

Family

ID=9494746

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933721T ATE220669T1 (de) 1996-08-01 1997-07-11 Verbindungen aus der gruppe der 3-aryl-2,4-dioxo- oxazolidine und ihre verwendung in der kosmetik und pharmazie

Country Status (11)

Country Link
US (1) US6057351A (de)
EP (1) EP0915857B1 (de)
JP (1) JP3335641B2 (de)
AR (1) AR008107A1 (de)
AT (1) ATE220669T1 (de)
AU (1) AU3697297A (de)
CA (1) CA2261095C (de)
DE (1) DE69714048T2 (de)
ES (1) ES2181014T3 (de)
FR (1) FR2751965B1 (de)
WO (1) WO1998005654A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024366A1 (de) * 1998-10-23 2000-05-04 Aventis Pharma Deutschland Gmbh Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen
US6953859B2 (en) * 2001-06-05 2005-10-11 Showa Denko K.K. Production process for 5-alkyl-oxazolidin-2,4-dione
FR2918885B1 (fr) 2007-07-17 2009-08-28 Oreal Utilisation d'extrait de bacterie cultivee sur eau thermale pour diminuer les poches et/ou les cernes perioculaires
FR3015282B1 (fr) 2013-12-20 2016-01-22 Oreal Utilisation cosmetique d'une huile essentielle de laserpitium siler l. pour les matieres keratiniques.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1284516A (fr) * 1957-11-20 1962-02-16 France Etat Produits utilisables notamment comme agents susceptibles d'agir sur la croissance des plantes et leur procédé de fabrication
CA926407A (en) * 1967-12-01 1973-05-15 Horiuchi Fukashi 3-(3,4-dichlorophenyl) oxazolidine-2,4-dione derivatives
DE2207576C2 (de) * 1972-02-18 1985-07-25 Basf Ag, 6700 Ludwigshafen Oxazolidinderivate
FR2275206A1 (fr) * 1974-06-21 1976-01-16 Roussel Uclaf Application d'une oxazolidinedione a titre de medicament
IT1109545B (it) * 1978-02-24 1985-12-16 Montedison Spa Derivati di n-fenil-1,3-ossazolidin-2,4-dionifungicidi e procedimento di preparazione
DE3115650A1 (de) * 1981-04-18 1982-11-04 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten oxazolidin-2,4-dionen
DE3325734A1 (de) * 1983-07-16 1985-01-24 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von n-(3,5-dichlorphenyl)-oxazolidin-2,4-dionen
EP0382884A1 (de) * 1989-02-17 1990-08-22 Sagami Chemical Research Center Oxazolidindion-Verbindungen, Verfahren zu ihrer Herstellung und diese enthaltende herbizide Zusammensetzungen

Also Published As

Publication number Publication date
US6057351A (en) 2000-05-02
FR2751965A1 (fr) 1998-02-06
AR008107A1 (es) 1999-12-09
AU3697297A (en) 1998-02-25
DE69714048D1 (de) 2002-08-22
CA2261095C (fr) 2004-01-27
JP3335641B2 (ja) 2002-10-21
CA2261095A1 (fr) 1998-02-12
FR2751965B1 (fr) 1998-11-27
WO1998005654A1 (fr) 1998-02-12
DE69714048T2 (de) 2002-11-14
EP0915857A1 (de) 1999-05-19
JP2000505092A (ja) 2000-04-25
EP0915857B1 (de) 2002-07-17
ES2181014T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
ATE302754T1 (de) Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59905572D1 (de) Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
ATE299148T1 (de) Substituierte isochinolin-3-carbonsäureamide, ihre herstellung und ihre verwendung als arzneimittel
DE69727837D1 (de) Neue antidiabetische verbindungen mit hypolipidimischen und antihypertensiven eigenschaften, verfahren zu ihrer herstellung und ihre enthaltenden arzneimittel
TR199501673A1 (tr) Aerosol ilac formülleri.
DE69726593D1 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor- und antivirale mittel
DE69516036D1 (de) Aromatische Verbindungen und ihre Verwendung in der Parfümerie
DE69814431D1 (de) 3,3-diarylpropylamine , ihre verwendung und herstellung
TR199802624A3 (tr) Yeni farmasötik.
ATE439439T1 (de) Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung
ATE205476T1 (de) Acryloyl-substituierte distamycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als antitumor- und antivirale mittel
ATE210638T1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE69913437D1 (de) Wasserfreie Zusammensetzung, ihre Verwendung in der Kosmetik, Pharmazie oder Körperhygiene
ATE301645T1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
HK1049655A1 (en) Substituted norbornylamino derivatives, productionand use thereof and medicaments containing them.
DE59811477D1 (de) Substituierte 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE220669T1 (de) Verbindungen aus der gruppe der 3-aryl-2,4-dioxo- oxazolidine und ihre verwendung in der kosmetik und pharmazie
DE59906907D1 (de) Phosphororganische verbindungen und ihre verwendung
DE69600090T2 (de) Cyclodextrin-Derivate und ihre Verwendung, insbesondere in der Kosmetik
ATE223921T1 (de) Phosphororganische verbindungen und ihre verwendung
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.
ATE113600T1 (de) Benzodiazepinverbindungen und ihre verwendung als arzneimittel.
DE59902408D1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE69811651D1 (de) Enthaarungszusammensetzungen, die bereitung und die verwendung derselben
ATE263755T1 (de) Neue antiestrogene, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties